Kaival Brands (OTCQB: KAVL) today announced that Bidi Vapor LLC has successfully completed the regulatory process to enter seven additional international markets. This brings the total of new international countries open for distribution to 11, including Australia, Austria, the Czech … Continue reading →

Kaival Brands (OTC: KAVL), a company focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets, has scheduled an investor call for Wednesday, April 14. Hosted by Kaival Brands CEO Niraj Patel, … Continue reading →

Kaival Brands (OTCQB: KAVL) today announced that Bidi Vapor LLC, the manufacturer of the products for which Kaival Brands acts as the exclusive global distributor, successfully completed the regulatory process to enter four new, significant markets. Bidi Vapor’s primary offering, … Continue reading →

Kaival Brands Innovations Group (KAVL), a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, has noted recent news from China outlining increased supervision over the e-cigarette category. KAVL, which is the exclusive global distributor of … Continue reading →

Kaival Brands Innovations Group (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant brands within their respective markets, has met a significant requirement in the process of uplisting to the Nasdaq. The company … Continue reading →

Kaival Brands (OTCQB: KAVL), a company focused on generating stockholder value by incubating innovative products into mature and dominant brands, is the exclusive global distributor of all products manufactured by Bidi Vapor LLC. Bidi Vapor’s primary offering, the Bidi (R) … Continue reading →